Helaina: $45 Million (Series B) Raised To Transform Nutrition With Human Equivalent Bioactive Proteins
By Amit Chowdhry ● Sep 28, 2024
Helaina, a biotechnology company transforming nutrition with human equivalent bioactive proteins, announced it raised $45 million in Series B funding, bringing its total equity funding to $83 million. This funding round was led by Avidity Partners, with additional investment from Spark Capital, Ingeborg Investments, Tom Williams of Heron Rock, Barrel Ventures, Siam Capital, Relish Works, CF Private Equity, and Primary Venture Partners, among other strategic partners.